Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-26T03:40:01.195Z Has data issue: false hasContentIssue false

43 - Personality disorder

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

Anthony Bateman
Affiliation:
Halliwick Unit St Ann's Hospital St Ann's Road London UK
Mary Zanarini
Affiliation:
McLean Hospital Belmont, MA USA
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

The literature on effective treatments of the personality disorders is quite large but evidence remains sparse. There are a number of personality disorders for which there is absolutely no evidence and/or no studies examining possible evidence for efficacy, and these disorders, schizoid, histrionic, narcissistic, obsessive-compulsive and dependent are not covered in this chapter (but mentioned in the following one on other less-established treatments for personality disorder). Many descriptions of treatment for these disorders are really combinations of theory with clinical supposition but very little evidence. The evidence for some psychotherapeutic intervention is strongest for borderline personality disorder (BPD) and the evidence for psychopharmacological interventions is strongest for schizotypal personality disorder (STPD). Even well-designed studies are confounded by Axis I and Axis II co-morbidities, and this limits interpretation of the findings. The reader will note the importance given to the structuring and organization of treatment and might also consult the chapter on complex interventions in evaluating the significance of the findings.

Introduction

The definition of personality disorder (PD) remains controversial. Both the DSM-IV and ICD-10 take a categorical approach to the diagnosis of PD defining different types of personality according to descriptive criteria. Tyrer et al. (1990), however, found little evidence that categories of personality disorder were helpful in determining response to treatment or indeed that they had any predictive value at all. Research orientated methods rely on structured and semi-structured interviewing or self-report screening measures. Although this improves reliability somewhat, the approach remains unsatisfactory (Pilkonis et al., 1995).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alden, L. (1989). Short-term structured treatment for avoidant personality disorder. Journal of Consulting and Clinical Psychology, 57, 756–64.Google Scholar
Alden, L. E. & Capreol, M. J. (1993). Avoidant personality disorder: Interpersonal problems as predictors of treatment response. Behavioural Therapy, 24, 357–76.Google Scholar
Alford, B. & Beck, A. (1997). The Integrative Power of Cognitive Therapy. New York: Guilford Press.
Barber, J. P. & Muenz, L. R. (1996). The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. Journal of Consulting and Clinical Psychology, 64, 951–58.Google Scholar
Barber, J. P., Morse, J. Q., Krakauer, I. D.et al. (1997). Change in obsessive-compulsive and avoidant personality disorders following Time-limited Supportive-expressive therapy. Psychotherapy, 34, 133–43.Google Scholar
Bateman, A. & Fonagy, P. (1999). The effectiveness of partial hospitalization in the treatment of borderline personality disorder – a randomised controlled trial. American Journal of Psychiatry, 156, 1563–9.Google Scholar
Bateman, A. & Fonagy, P. (2000). Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138–43.Google Scholar
Bateman, A. & Fonagy, P. (2001). Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalisation: an 18-month follow-up. American Journal of Psychiatry, 158, 36–42.Google Scholar
Bateman, A. & Fonagy, P. (2003). Health service utilisation costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalisation versus general psychiatric care. American Journal of Psychiatry, 160, 169–171.Google Scholar
Bateman, A. & Fonagy, P. (2004). Psychotherapy for Borderline Personality Disorder: Mentalisation Based Treatment. Oxford: Oxford University Press.
Bateman, A. & Fonagy, P. (2006). Mentalization Based Treatment: A Practical Guide, Oxford: Oxford University Press.
Beck, A. T., Ward, C. H., Mendelson, M.et al. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–71.Google Scholar
Bender, D. S., Dolan, R. T., Skodol, A. E.et al. (2001). Treatment utilisation by patients with personality disorders. American Journal of Psychiatry, 158, 295–302.Google Scholar
Benedetti, F., Sforzini, L. & Colombo, C. (1998). Low dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry, 59, 103–7.Google Scholar
Blatt, S. J., Stayner, D. A., Auerbach, J. S. & Behrends, R. S. (1996). Change in object and self-representations in long-term, intensive, inpatient treatment of seriously disturbed adolescents and young adults. Psychiatry, 59, 82–107.Google Scholar
Bogenschutz, M. & Nurnberg, H. (2004). Olanzapine versus placebo in the treatment if borderline personality disorder. Journal of Clinical Psychiatry, 65, 104–9.Google Scholar
Bohus, M., Landwehrmeyer, G., Stiglmayr, C.et al. (1999). Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. Journal of Clinical Psychiatry, 60, 598–603.Google Scholar
Bohus, M., Haaf, B., Simms, T.et al. (2002). Effectiveness of inpatient Dialectical Behavioural Therapy for Borderline Personality Disorder: a controlled trial. In 5th ISSPD European Congress on Personality Disorders – Abstracts, pp. 18. Munich, Germany.
Byford, S., Knapp, M., Greenshields, J.et al. (2003). Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychological Medicine, 33, 977–86.Google Scholar
Campbell, M., Fitzpatrick, R., Haines, A.et al. (2000). A framework for the design and evaluation of complex interventions to improve health. British Medical Journal, 321, 694–6.Google Scholar
Chengappa, K., Ebeling, T., Kang, J.et al. (1999). Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry, 60, 477–84.Google Scholar
Chiesa, M. & Fonagy, P. (2003). Psychosocial treatment for severe personality disorder: 36-month follow-up. British Journal of Psychiatry, 183, 356–62.Google Scholar
Chiesa, M., Fonagy, P., Holmes, J.et al. (2002). Health Service use costs by personality disorder following specialist and non-specialist treatment: a comparative study. Journal of Personality Disorders, 16, 160–73.Google Scholar
Chiesa, M., Fonagy, P., Holmes, J.et al. (2004). Residential versus community treatment of personality disorders: a comparative study of three treatment programmes. American Journal of Psychiatry, 161, 1463–70.Google Scholar
Clark, L. A., Vittengl, J., Kraft, D.et al. (2003). Separate personality traits from states to predict depression. Journal of Personality Disorders, 17, 152–72.Google Scholar
Clarkin, J. F. (2002). 5th ISSPD European Congress on Personality Disorders. In Personality Disorders: Neurobiology and Psychotherapy. Munich.
Clarkin, J. F., Foelsch, P., Levy, K.et al. (2001). The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioural change. Journal of Personality Disorders, 15, 487–95.Google Scholar
Clarkin, J. F., Levy, K. N., Lenzenweger, M. F.et al. (2004). The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomised controlled trial for borderline personality disorder: rationale, methods, and patient characteristics. Journal of Personality Disorders, 18, 52–72.Google Scholar
Coccaro, E., Harvey, P., Kupsaw-Lawrence, E.et al. (1991). Development of neuropharmacologically based behavioural assessments of impulsive aggressive behaviour. Journal of Neuropsychiatry and Clinical Neuroscience, 3 (Suppl.), 44–51.Google Scholar
Copas, J. B., O'Brien, M., Roberts, J.et al. (1984). Treatment outcome in personality disorders: the effect of social, psychological and behavioural variables. Personality and Individual Differences, 5, 565–73.Google Scholar
Cornelius, J., Soloff, P., Perel, J.et al. (1990). Fluoxetine trial in borderline personality disorder. Psychopharmacology Bulletin, 26, 151–4.Google Scholar
Davidson, K. & Tyrer, P. (1996). Cognitive therapy for antisocial and borderline personality disorders: single case study series. British Journal of Clinical Psychology, 35, 413–29.Google Scholar
Davidson, K., Norrie, J. & Tyrer, P. (2006a). The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. Journal of Personality Disorders, 20(5), 450–65.Google Scholar
Davidson, K., Tyrer, P., Gumley, A.et al. (2006b). A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. Journal of Personality Disorders, 20, 431–49.Google Scholar
Davidson, K., Scott, J., Schmidt, U.et al. (2004). Therapist competence and clinical outcome in the Prevention of Parasuicide by Manual Assisted Cognitive Behaviour Therapy Trial: the POPMACT study. Psychological Medicine, 34, 855–63.Google Scholar
Davies, S., Campling, P. & Ryan, K. (1999). Therapeutic Community provision at regional and district levels. Psychiatric Bulletin, 23, 79–83.Google Scholar
Derogatis, L. R. (1983). SCL-90R: Administration, Scoring and Procedures – Manual II. Towson, MD: Clinical Psychometric Research Inc.
Dolan, B., Warren, F. & Norton, K. (1997). Change in borderline symptoms one year after therapeutic community treatment for severe personality disorder. British Journal of Psychiatry, 171, 272–9.Google Scholar
Donnelly, J. & Guy, S. (1998). Evaluation of a first stage pilot project to address offending behaviour in a mentally disordered population in Scotland. Psychiatric Care, 5, 106–8.Google Scholar
D'Silva, K., Duggan, C. & Mccarthy, L. (2004). Does treatment really make psychopaths worse? A review of the evidence. Journal of Personality Disorders, 18, 163–77.Google Scholar
Ekselius, L., Tillfors, M., Furmark, T.et al. (2001). Personality Disorder in the general population: DSM-IV and ICD-10 defined prevalence as related to sociodemographic profile. Personality and Individual Differences, 30, 311–20.Google Scholar
Emmelkamp, P. M., Benner, A., Kuipers, A., Feiertag, G. A.Koster, H. C. & Apeldoorn, F. J. (2006). Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. British Journal of Psychiatry, 189, 60–4.Google Scholar
Evans, K., Tyrer, P., Catalan, J.et al. (1999). Manual-assisted cognitive-behaviour therapy (MACT): a randomised controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychological Medicine, 29, 19–25.Google Scholar
Feske, U., Mulsant, B., Pilkonis, P. A.et al. (2004). Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. American Journal of Psychiatry, 161, 2073–80.Google Scholar
Feske, U., Perry, K. J., Chambless, D. L.et al. (1996). Avoidant Personality Disorder as a predictor for treatment outcomes among generalised social phobics. Journal of Personality Disorders, 10, 174–84.Google Scholar
Fisher, M. & Bentley, K. (1996). Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder. Psychiatric Services, 11, 1244–50.Google Scholar
Fonagy, P. & Bateman, A. (2006). Progress in the treatment of borderline personality disorder. British Journal of Psychiatry, 188, 1–3.Google Scholar
Frankenburg, F. R. & Zanarini, M. C. (1993). Clozapine treatment in borderline patients: a preliminary study. Comprehensive Psychiatry, 34, 402–405.Google Scholar
Frankenburg, F. R. & Zanarini, M. C. (2002). Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double blind placebo controlled pilot study. Journal of Clinical Psychiatry, 63, 442–6.Google Scholar
Gabbard, G. O., Lazar, S. G., Hornberger, J.et al. (1997). The economic impact of psychotherapy: a review. American Journal of Psychiatry, 154, 147–55.Google Scholar
Gabbard, G., Coyne, L., Allen, J.et al. (2000). Evaluation of intensive in-patient treatment of patients with severe personality disorders. Psychiatric Services, 51, 893–8.Google Scholar
Giesen-Bloo, J., Dyck, R., Spinhoven, P.et al. (2006). Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Archives of General Psychiatry, 63, 649–58.Google Scholar
Gunderson, J. G., Kolb, J. E. & Austin, V. (1981). The diagnostic interview for borderline patients. American Journal of Psychiatry, 138, 896–903.Google Scholar
Haigh, R. (2002). Therapeutic community research: past, present and future. Psychiatric Bulletin, 26, 68–70.Google Scholar
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Hare, R. (1991). The Hare Psychopathy Checklist – Revised. Toronto: Multi-Health Systems.
Hill, J., Harrington, R. C., Fudge, H.et al. (1989). Adult personality functioning assessment (APFA): an investigation-based standardised interview. British Journal of Psychiatry, 161, 24–35.Google Scholar
Hollander, E., Allen, A., Lopez, R.et al. (2001). A preliminary double blind, placebo controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry, 62, 199–203.Google Scholar
Hughes, G. & Hogue, T. (1997). First-stage evaluation of a treatment programme for personality disordered offenders. Journal of Forensic Psychiatry, 8, 515–27.Google Scholar
Karterud, S., Vaglum, S., Friis, S.et al. (1992). Day hospital therapeutic community treatment for patients with personality disorder: an empirical evaluation of the containment function. The Journal of Nervous and Mental Disease, 180, 238–43.Google Scholar
Karterud, S., Pedersen, G., Bjordal, E.et al. (2003). Day treatment of patients with personality disorders: experiences from a Norwegian treatment research network. Journal of Personality Disorders, 17, 243–62.Google Scholar
Koenigsberg, H. W., Reynolds, D. & Goodman, L. (2003). Risperidone in the treatment of schizotypal personality disorder. Journal of Clinical Psychiatry, 64, 628–34.Google Scholar
Koerner, K. & Linehan, M. M. (1992). Integrative therapy for borderline personality disorder: dialectical behaviour therapy. In Handbook of Psychotherapy Integration, ed. Norcross, J. C. G., pp. 433–59. New York: Basic Books.
Koons, C., Robins, C. & Tweed, J. (2000). Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behavior Therapy, 32, 371–90.Google Scholar
Lees, J., Manning, N. & Rawlings, B. (1999). Therapeutic community effectiveness. A systematic international review of therapeutic community treatment for people with personality disorders and mentally disordered offenders. NHS Centre for Reviews and Dissemination: University of York, CRD Report 17.
Lees, J., Manning, N. & Rawlings, B. (2004). A culture of enquiry: research evidence and the therapeutic community. Psychiatric Quarterly, 75, 279–94.Google Scholar
Leichsenring, F. & Leibing, E. (2003). The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: a meta-analysis. American Journal of Psychiatry, 160, 1223–32.Google Scholar
Levendusky, P. (2000). Dialectical behavior therapy: so far so soon. Clinical Psychology Science and Practice, 7, 99–100.Google Scholar
Linehan, M. M. (1987). Dialectical behavioural therapy: A cognitive behavioural approach to parasuicide. Journal of Personality Disorders, 1, 328–33.Google Scholar
Linehan, M. M. (1993). The Skills Training Manual for Treating Borderline Personality Disorder. New York: Guilford Press.
Linehan, M. & Heard, H. (1993). Impact of treatment accessibility on clinical course of parasuicidal patients: reply. Archives of General Psychiatry, 50, 157–8.Google Scholar
Linehan, M. M., Armstrong, H., Suarez, A.et al. (1991). Cognitive-behavioural treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–64.Google Scholar
Linehan, M. M., Heard, H. L. & Armstrong, H. E. (1993). Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry, 50, 971–4.Google Scholar
Linehan, M., Dimeff, L., Reynolds, S.et al. (2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence, 67, 13–26.Google Scholar
Linehan, M. M., Comtois, K. A., Murray, A. M.et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–66.Google Scholar
Longabaugh, R., Wirtz, P. W., DiClemente, C. C.et al. (1994). Issues in the development of client-treatment matching hypotheses. Journal of Studies on Alcohol. 12 (Suppl.), 46–59.Google Scholar
Lynch, T. R., Chapman, A. L., Rosenthal, M. Z.et al. (2006). Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations. Journal of Clinical Psychology, 62, 459–80.Google Scholar
Maden, T. & Tyrer, P. (2003). Dangerous and severe personality disorders: a new concept from the United Kingdom. Journal of Personality Disorders, 17, 489–96.Google Scholar
Main, T. (1957). The ailment. British Journal of Medical Psychology, 30, 129–45.Google Scholar
Markovitz, P. J. (1995). Pharmacotherapy of impulsivity, aggression, and related disorders. In Impulsivity and Aggression, ed. Hollander, E. & Stein, D.. Chichester, UK: John Wiley.
Markovitz, P. J. & Wagner, C. (1995). Venlafaxine in the treatment of borderline personality disorder. Psychopharmacology Bulletin, 31, 773–7.Google Scholar
Markovitz, P. J., Calabrese, J., Schulz, S. C.et al. (1991). Fluoxetine in treatment of borderline and schizotypal personality disorders. American Journal of Psychiatry, 148, 1064–7.Google Scholar
Marlowe, M. J., O'Neill-Byrne, K., Lowe-Ponsford, F.et al. (1996). The borderline syndrome index: a validation study using the personality assessment schedule. British Journal of Psychiatry, 168, 72–5.Google Scholar
Marziali, E. & Monroe-Blum, H. (1995). An interpersonal approach to group psychotherapy with borderline personality disorder. Journal of Personality Disorders, 9, 179–89.Google Scholar
Marzillier, J. S., Lambert, C. & Kelett, J. (1976). A controlled evaluation of systematic desensitisation and social skills training for socially inadequate psychiatric patients. Behavioural Research and Therapy, 14, 225–38.Google Scholar
McGlashan, T. H. (1986). Schizotypal personality disorder. Chestnut Lodge follow-up study: long-term follow-up perspectives. Archives of General Psychiatry, 43, 329–34.Google Scholar
Mersch, P. P., Jansen, M. A. & Arntz, A. (1995). Social phobia and personality disorder: severity of complaint and treatment effectiveness. Journal of Personality Disorders, 9, 143–59.Google Scholar
Montgomery, S. & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 135, 382–9.Google Scholar
Nickel, M. K., Muehlbacher, M, Nickel, C.et al. (2006). Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry, 163, 833–8.Google Scholar
Norden, M. J. (1989) Fluoxetine in borderline personality disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, 885–93.Google Scholar
Oldham, J., Phillips, K., Gabbard, G.et al. (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. American Journal of Psychiatry, 158, 1–52.Google Scholar
Overall, J. & Gorham, D. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812.Google Scholar
Perry, J. C., Banon, E. & Ianni, F. (1999). Effectiveness of psychotherapy for personality disorder. American Journal of Psychiatry, 156, 1312–21.Google Scholar
Pilkonis, P. A., Heape, C. L., Proietti, M. S.et al. (1995). The reliability and validity of two structured interviews for personality disorders. Archives of General Psychiatry, 52, 1029–33.Google Scholar
Pinto, O. & Akiskal, H. (1998). Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. Journal of Affective Disorders, 51, 333–43.Google Scholar
Project Match Research Group (1998). Therapists effects in three treatments for alcohol problems. Psychotherapy Research, 8, 455–74.
Putnam, K. & Silk, K. R. (2005). Emotion dysregulation and the development of borderline personality disorder. Development and Psychopathology, 17, 899–925.Google Scholar
Quale, M. & Moore, E. (1998). Evaluating the impact of structured group work with men in a high security hospital. Criminal Behaviour and Mental Health, 8, 77–92.Google Scholar
Raine, A., Mellingen, K., Liu, J.et al. (2003). Effects of environmental enrichment at ages 3–5 years on schizotypal personality and antisocial behavior at ages 17 and 23. American Journal of Psychiatry, 196, 1627–35.Google Scholar
Renneberg, B., Goldstein, A. J., Phillips, D.et al. (1990). Intensive behavioural group treatment of avoidant personality disorder. Behaviour Therapy, 21, 363–77.Google Scholar
Rice, M. E., Harris, G. T. & Cormier, C. A. (1992). An evaluation of a maximum-security therapeutic community for psychopaths and other mentally disordered offenders. Law and Human Behaviour, 16, 399–412.Google Scholar
Rinne, T., Brink, W., Wouters, L.et al. (2002). SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry, 159, 2048–54.Google Scholar
Robins, C. (2003). Dialectical behavior therapy for borderline personality disorder. Psychiatric Annals, 32, 608–16.Google Scholar
Rocca, P., Marchiaro, L., Cocuzza, E.et al. (2002). Treatment of borderline personality disorder with risperidone. Journal of Clinical Psychiatry, 63, 241–4.Google Scholar
Rosser, R., Birch, S., Bond, H.et al. (1987). Five year follow-up of patients treated with in-patient psychotherapy at the Cassel Hospital for Nervous Diseases. Journal of the Royal Society of Medicine, 80, 549–55.Google Scholar
Rutter, D. & Tyrer, P. (2003). The value of therapeutic communities in the treatment of personality disorder: a suitable place for treatment?Journal of Psychiatric Practice, 9, 291–302.Google Scholar
Ryle, A. (2004). The contribution of cognitive analytic therapy to the treatment of borderline personality disorder. Journal of Personality Disorders, 18, 3–35.Google Scholar
Ryle, A. & Golynkina, K. (2000). Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. British Journal of Medical Psychology, 73, 197–210.Google Scholar
Safran, J. D. & Segal, Z. V. (1990). Interpersonal Process in Cognitive Therapy. New York: Basic Books.
Salzman, C., Wolfson, A., Schatzberg, A.et al. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15, 23–9.Google Scholar
Sara, G., Raven, P. & Mann, A. (1996). A comparison of DSM-IIIR and ICD10 personality disorder criteria in an outpatient population. Psychological Medicine, 26, 151–60.Google Scholar
Saunders, D. (1996). Feminist cognitive behavioral and process-psychodynamic treatment for men who batter: interaction of abuser traits and treatment models. Violence and Victims, 11, 393–414.Google Scholar
Scheel, K. (2000) The empirical basis of dialectical behavior therapy: summary, critique, and implications. Clinical Psychology Science and Practice, 7, 68–86.Google Scholar
Schulz, S., Camlin, K., Berry, S.et al. (1999a). Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biological Psychiatry, 46, 1429–35.Google Scholar
Schulz, S. C., Camlin, K. L., Berry, S. A.et al. (1999b). A controlled study of Risperidone for borderline personality disorder. In 7th International Congress on Schizophrenia Research, pp. 296–297. Santa Fe, New Mexico: Schizophrenia Research.
Schwarz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases, 20, 637–48.Google Scholar
Shearin, E. & Linehan, M. M. (1992). Patient–therapist ratings and relationship to progress in dialectical behaviour therapy for borderline personality disorder. Behaviour Therapy, 23, 730–41.Google Scholar
Siever, L. J. & Davis, K. L. (1991). A psychobiological perspective on the personality disorders. American Journal of Psychiatry, 148, 1647–58.Google Scholar
Siever, L. J., Torgersen, S., Gunderson, J. G.et al. (2002). The borderline diagnosis III: identifying endophenotypes for genetic studies. Biological Psychiatry, 51, 964–8.Google Scholar
Slade, M. & Priebe, S. (2001). Are randomised controlled trials the only gold that glitters?British Journal of Psychiatry, 179, 286–7.Google Scholar
Stein, D., Simeon, D., Frenkel, M.et al. (1995). An open trial of valproate in borderline personality disorder. Journal of Clinical Psychiatry, 56, 506–10.Google Scholar
Stone, M. (1993). Long-term outcome in personality disorders. British Journal of Psychiatry, 162, 299–313.Google Scholar
Stravynski, A., Marks, I. & Yule, W. (1982). Social skills problems in neurotic outpatients: social skills training with and without cognitive modification. Archives of General Psychiatry, 39, 1378–85.Google Scholar
Stravynski, A., Belisle, M., Marcoulier, M.et al. (1994). The treatment of avoidant personality disorder by social skills training in the clinic or in real-life settings. Canadian Journal of Psychiatry, 39, 377–83.Google Scholar
Swenson, C. (2000). How can we account for DBT's widespread popularity. Clinical Psychology: Science and Practice, 7, 87–91.Google Scholar
Tucker, L., Bauer, S. F., Wagner, et al. (1987). Long-term hospital treatment of borderline patients: a descriptive outcome study. American Journal of Psychiatry, 144, 1443–1448.Google Scholar
Turkat, I. D. & Maisto, S. A. (1985). Personality disorders: application of the experimental method to the formulation of personality disorders. In Clinical Outcome of Psychological Disorders, ed. Barlow, D. H.. New York: Guilford Press.
Turner, R. (2000a). Naturalistic evaluation of dialectical behaviour therapy-orientated treatment for borderline personality disorder. Cognitive and Behavioural Practice, 7, 413–19.Google Scholar
Turner, R. (2000b). Understanding dialectical behaviour therapy. Clinical Psychology Science and Practice, 7, 95–8.Google Scholar
Tyrer, P. (2002). Practice guideline for the treatment of borderline personality disorder: a bridge too far. Journal of Personality Disorders, 16, 113–18.Google Scholar
Tyrer, P., Seivewright, N., Ferguson, B.et al. (1990). The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychological Medicine, 20, 423–31.Google Scholar
Tyrer, P., Jones, V. & Thompson, S. (2003). Service variation in baseline variables and prediction of risk in a randomised controlled trial of psychological treatment in repeated parasuicide: the POPMACT study. International Journal of Social Psychiatry, 49, 58–69.Google Scholar
Tyrer, P., Tom, B., Byford, S.et al. (2004). Differential effects of manual assisted cognitive behaviour therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. Journal of Personality Disorders, 18, 102–16.Google Scholar
Vaglum, P., Friis, S., Irion, T.et al. (1990). Treatment response of severe and nonsevere personality disorders in a therapeutic community day unit. Journal of Personality Disorders, 4, 161–72.Google Scholar
Velzen, C. J. M., Emmelkamp, P. M. G. & Scholing, A. (1997). The impact of personality disorders on behavioural treatment outcome for social phobia. Behaviour Research and Therapy, 35, 889–900.Google Scholar
Verheul, R.Bosch, L. M., Koeter, M. W.et al. (2003). Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. British Journal of Psychiatry, 182, 135–40.Google Scholar
Wilberg, T., Friis, S., Karterud, S.et al. (1998). Outpatient group psychotherapy: a valuable continuation treatment for patients with borderline personality disorder treated in a day hospital? A 3-year follow-up study. Nordic Journal of Psychiatry, 52, 213–22.Google Scholar
Wilcox, J. (1995). Divalproex sodium as a treatment for borderline personality disorder. Annals of Clinical Psychiatry, 7, 33–7.Google Scholar
Winston, A., Pollack, J., McCullough, L.et al. (1991). Brief psychotherapy of personality disorders. Journal of Nervous and Mental Disease, 179, 188–93.Google Scholar
Winston, A., Laikin, M., Pollack, J.et al. (1994). Short-term dynamic psychotherapy of personality disorders. American Journal of Psychiatry, 15, 190–4.Google Scholar
Woody, G. E., McLellan, T., Luborsky, L.et al. (1985). Sociopathy and psychotherapy outcome. Archives of General Psychiatry, 179, 188–93.Google Scholar
Young, J. E. (1990). Cognitive Therapy for Personality Disorders: A Schema-focused Approach. Sarasota, Florida: Professional Resource Exchange.
Young, R., Biggs, J., Ziegler, V.et al. (1978). A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429–35.Google Scholar
Zanarini, M. C. & Frankenburg, F. R. (1997). Pathways to the development of borderline personality disorder. Journal of Personality Disorders, 11, 93–104.Google Scholar
Zanarini, M. C. & Frankenburg, F. R. (2001). Olanzapine treatment of borderline patients: a double-blind, placebo-controlled study. Journal of Clinical Psychiatry.Google Scholar
Zanarini, M. C. & Frankenburg, F. R. (2003). Omega-3 fatty acid treatment of women with borderline personality disorder. American Journal of Psychiatry, 160, 167–9.Google Scholar
Zanarini, M. C., Gunderson, J., Frankenburg, F. R.et al. (1989). The revised Diagnostic Interview for Borderlines: discriminating BPD from other Axis II disorders. Journal of Personality Disorders, 3, 10–18.Google Scholar
Zanarini, M. C., Frankenburg, F. R., Dubo, E.et al. (1998). Axis 1 comorbidity of borderline personality disorder. American Journal of Psychiatry, 155, 1733–9.Google Scholar
Zanarini, M. C., Frankenburg, F. R., Khera, G. S.et al. (2001). Treatment histories of borderline patients. Comprehensive Psychiatry, 42, 144–50.Google Scholar
Zanarini, M. C., Frankenburg, F. R., Hennen, J.et al. (2003a). The Longitudinal Course of Borderline Psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry, 160, 274–83.Google Scholar
Zanarini, M. C., Vujanovic, A. A., Parachini, E. A.et al. (2003b). Zanarini rating scale for borderline personality disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. Journal of Personality Disorders, 17, 233–42.Google Scholar
Zanarini, M. C., Frankenburg, F. R., Hennen, J.et al. (2004a). Axis 1 comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. American Journal of Psychiatry, 161, 2108–14.Google Scholar
Zanarini, M. C., Frankenburg, F. R., Hennen, J.et al. (2004b). Mental Health Service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. Journal of Clinical Psychiatry, 65, 28–36.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Personality disorder
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.045
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Personality disorder
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.045
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Personality disorder
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.045
Available formats
×